Galunisertib


CAS No. : 700874-72-2

(Synonyms: LY2157299)

700874-72-2
Price and Availability of CAS No. : 700874-72-2
Size Price Stock
5mg $50 In-stock
10mg $70 In-stock
50mg $150 In-stock
100mg $250 In-stock
200mg $375 In-stock
500mg $750 In-stock
1g $1125 In-stock
5 g Get quote
10 g Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-13226
M.Wt: 369.42
Formula: C22H19N5O
Purity: >98 %
Solubility: DMSO : 100 mg/mL (ultrasonic)
Introduction of 700874-72-2 :

Galunisertib (LY2157299) is an oral and selective TGF-β receptor type I (TGF-βRI) kinase inhibitor with an IC50 of 56 nM. IC50 & Target: IC50: 56 nM (TGF-βRI)[4] In Vitro: Galunisertib (LY2157299) (0.1, 1, 10, and 100 μM) displays a slight dose-dependent potentiation of Bay 43-9006 in SK-Sora, HepG2, and Hep3B cell lines but not in JHH6, SK-HEP1, and HuH7 cell lines[2]. In Vivo: Human xenografts Calu6 (non-small cell lung cancer) and MX1 (breast cancer) are implanted subcutaneously in nude mice. After oral administration of 75 mg/kg, Galunisertib (LY2157299) induces a 70% decrease in pSmad for both types of cell lines. The time at which pSmad recovered 80% of baseline is approximately 6 h after administration[3].

Your information is safe with us.